Sei Investments Co. Sells 43,084 Shares of Aveanna Healthcare Holdings Inc. $AVAH

Sei Investments Co. lessened its holdings in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 53.7% during the first quarter, Holdings Channel.com reports. The firm owned 37,195 shares of the company’s stock after selling 43,084 shares during the quarter. Sei Investments Co.’s holdings in Aveanna Healthcare were worth $240,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the business. Caitong International Asset Management Co. Ltd increased its holdings in Aveanna Healthcare by 252.4% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock valued at $27,000 after purchasing an additional 2,400 shares during the period. Quantbot Technologies LP acquired a new position in Aveanna Healthcare during the 2nd quarter worth about $43,000. Summit Securities Group LLC acquired a new position in Aveanna Healthcare during the 1st quarter worth about $53,000. Oxford Asset Management LLP bought a new stake in shares of Aveanna Healthcare in the 2nd quarter valued at about $64,000. Finally, Bayesian Capital Management LP bought a new stake in shares of Aveanna Healthcare in the 2nd quarter valued at about $85,000. Institutional investors own 87.96% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the company. Raymond James Financial increased their price target on Aveanna Healthcare from $13.00 to $15.00 and gave the company a “strong-buy” rating in a research note on Friday. BMO Capital Markets upped their target price on Aveanna Healthcare from $10.00 to $14.00 and gave the company an “outperform” rating in a report on Friday. Weiss Ratings reissued a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Thursday, July 2nd. Royal Bank Of Canada raised shares of Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 target price for the company in a research report on Wednesday, June 3rd. Finally, UBS Group raised their price target on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the stock a “neutral” rating in a report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $11.78.

Key Headlines Impacting Aveanna Healthcare

Here are the key news stories impacting Aveanna Healthcare this week:

• Positive Sentiment: Q2 results exceeded expectations. Revenue increased 13.7% year over year to $670.5 million, while net income rose to $40.3 million from $27.0 million. Adjusted EBITDA reached $95.4 million, up 8.0%, and adjusted EPS of $0.22 topped analyst estimates of $0.19. Aveanna Healthcare Second Quarter Financial Results and Revised 2026 Guidance
• Positive Sentiment: Management raised full-year guidance. Aveanna now expects 2026 revenue above $2.68 billion, compared with its previous $2.63 billion-$2.65 billion range, and adjusted EBITDA above $365 million, up from $338 million-$342 million. The company cited reimbursement improvements, preferred-payer relationships and continued demand for complex home care. AVAH Q2 Earnings Call Highlights Higher Growth Targets
• Positive Sentiment: Analysts lifted their price targets. BMO Capital Markets raised its target from $10 to $14 and maintained an “outperform” rating. UBS raised its target from $8 to $13, although it retained a “neutral” rating. The revisions signal improved earnings expectations and support the stock’s recent strength. Benzinga analyst price target updates
• Neutral Sentiment: Growth is concentrated in Private Duty Services, which generates roughly 83% of revenue. Rapid revenue expansion is offsetting pressure on gross margins across business segments, making margin trends an important focus for investors. Aveanna Healthcare Q2 Earnings Report

Aveanna Healthcare Stock Performance

Shares of AVAH stock opened at $12.32 on Monday. The company has a market cap of $2.69 billion, a P/E ratio of 10.02, a PEG ratio of 1.22 and a beta of 1.90. The stock has a 50 day simple moving average of $8.97 and a two-hundred day simple moving average of $7.75. The company has a debt-to-equity ratio of 4.47, a quick ratio of 1.16 and a current ratio of 1.16. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $5.93 and a fifty-two week high of $12.52.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings results on Thursday, August 13th. The company reported $0.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.17 by $0.05. The firm had revenue of $670.48 million for the quarter, compared to analysts’ expectations of $638.61 million. Aveanna Healthcare had a return on equity of 80.70% and a net margin of 10.56%. Research analysts forecast that Aveanna Healthcare Holdings Inc. will post 0.68 earnings per share for the current year.

Insider Activity at Aveanna Healthcare

In other Aveanna Healthcare news, major shareholder Robert M. Williams, Jr. sold 7,000,000 shares of the firm’s stock in a transaction on Wednesday, June 3rd. The shares were sold at an average price of $6.24, for a total value of $43,680,000.00. Following the completion of the sale, the insider directly owned 252,899 shares in the company, valued at approximately $1,578,089.76. This trade represents a 96.51% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, major shareholder Paul R. Vigano sold 7,000,000 shares of Aveanna Healthcare stock in a transaction on Wednesday, June 3rd. The shares were sold at an average price of $6.24, for a total transaction of $43,680,000.00. Following the completion of the sale, the insider directly owned 252,899 shares of the company’s stock, valued at approximately $1,578,089.76. This trade represents a 96.51% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 31,305,664 shares of company stock worth $215,555,910 over the last quarter. 5.30% of the stock is currently owned by insiders.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.